Chandra Devi

Chandra Devi

Auto-generated profile, based on publicly available information

Chandra Devi

Centre for Genetic Disorders, Institute of Science, Banaras Hindu University, Varanasi, India

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
4 April 2021 in bioRxiv
Verified
Preprint
Open access
PDF file
PRPrashant Ranjan
Prashant Ranjan
NENeha
Neha
CDChandra Devi
Chandra Devi
PDParimal Das
Parimal Das
Prevailing COVID-19 vaccines are based on the spike protein of earlier SARS-CoV-2 strain that emerged in Wuhan, China. The continuously evolving nature of SARS-CoV-2 resulting emergence of new variants raises the risk of immune absconds. During the last few months, several RBD (receptor-binding domain) variants have been reported to affect the vaccine efficacy considerably. Soon after reporting of a new double mutant variant (L452R & E484Q) in India, the country facing a deadlier second wave of infections which prompts researchers to suspects this variant to be accountable. To address the relevant concerns about this new variant affecting vaccine efficacy, we performed molecular simulation dynamics based structural analysis of spike protein of double mutant (L452R & E484Q) along with K417G variants and earlier reported RBD variants and found structural changes in RBD region after comparing with the wild type. Comparison of the binding affinity of the double mutant and earlier reported RBD variant for ACE2 (angiotensin 2 altered enzymes) receptor and CR3022 antibody with the wild-type strain revealed the lowest binding affinity of the double mutant for CR3022 among all other variants. These findings suggest that the newly emerged double mutant could significantly reduce the impact of the current vaccine which threatens the protective efficacy of current vaccine therapy.

8 June 2022 in Microbial Pathogenesis
Verified
Journal Article
Closed access
PRPrashant Ranjan
Prashant Ranjan
NENeha
Neha
CDChandra Devi
Chandra Devi
KDKaaviyapriya Arulmozhi Devar
Kaaviyapriya Arulmozhi Devar
PDParimal Das
Parimal Das

24 August 2024 in 3 Biotech
Verified
Journal Article
Closed access
PDF file
CDChandra Devi
Chandra Devi
PRPrashant Ranjan
Prashant Ranjan
SRSonam Raj
Sonam Raj
PDParimal Das
Parimal Das

3 September 2024 in medRxiv
Verified
Preprint
Open access
PDF file
PRPrashant Ranjan
Prashant Ranjan
CDChandra Devi
Chandra Devi
NVNeha Verma
Neha Verma
RBRajesh Bansal
Rajesh Bansal
VSVinay Kumar Srivastava
Vinay Kumar Srivastava
PDParimal Das
Parimal Das
This study reveals novel microRNAs (miRNAs) implicated in congenital tooth agenesis (CTA), a common dental anomaly with a complex genetic basis. Through a multi-omics approach combining bioinformatics, whole exome sequencing, metabolite analysis, and gene expression profiling, we identified eight key miRNAs potentially involved in tooth development. Among these, four miRNAs viz. miR-218-5p, miR-15b-5p, miR-200b-3p, and let-7a-3p were validated as significant regulators in CTA, marking their first investigation in blood samples from CTA patients. Our analysis revealed that these miRNAs play critical roles in odontogenesis, influencing essential signaling pathways, including Wnt, FGF , and PI3 kinase pathways. Among these four, miR-218-5p and let-7a-3p emerged as key players in dental tissue morphogenesis, each contributing to previously unidentified networks crucial for tooth development. This study highlights the potential of these miRNAs as non-invasive biomarkers for early CTA diagnosis and therapeutic targets. This is the first comprehensive investigation of these specific miRNAs in CTA, utilizing a multi-omics approach to offer fresh insights into miRNA-mediated mechanisms and their role in regulating dental anomalies. Our findings not only advance the understanding of the genetic regulation of tooth development but also pave the way for personalized approaches in managing dental anomalies. Further research is needed to validate these results and explore their clinical applications. Graphical

11 March 2025 in medRxiv
Verified
Preprint
Open access
PDF file
PRPrashant Ranjan
Prashant Ranjan
CDChandra Devi
Chandra Devi
VSVinay Kumar Srivastava
Vinay Kumar Srivastava
MCMeenakshi Chandel
Meenakshi Chandel
GJGarima Jain
Garima Jain
PDParimal Das
Parimal Das
Background: Congenital tooth agenesis (CTA) is a common developmental anomaly with complex genetic and molecular mechanisms. Previous studies have primarily focused on candidate gene mutations, often lacking a pan-omics perspective. Methods: This study integrates metabolomics, proteomics, microarray, and genomics with machine learning to identify biomarkers and elucidate disease mechanisms. A random forest-based classification achieved high AUC-ROC scores (0.95 for proteomics, 0.98 for metabolomics), validating the biomarker discovery framework. Results: Several biomarkers were identified in this study that enhance our understanding of CTA. Furthermore, our findings reveal a significant association between CTA and ecto-mesodermal diseases, which has not been extensively explored before. Notably, 24 dual-expression genes were expressed in both pre- and post-developmental stages, suggesting a regulatory role in tooth integrity, repair, and homeostasis. Metabolomics analysis revealed 28 upregulated and 17 downregulated metabolites uniquely associated with CTA. Key metabolic alterations involved nucleotide metabolism, purine metabolism, oxidative stress, and Wnt signaling. High-performing metabolites (AUC ≥ 0.90), including PEG n5 (0.99), PEG n6 (0.98), PEG-4 (0.97), PEG n7 (0.96), PEG n8 (0.95), caffeine (0.94), hydroxycaproic (0.91) and alpha-aspartylphenylalanine (0.90) demonstrated strong diagnostic potential. CTA patients showed 292 unique metabolites vs. 238 in controls, indicating metabolic pathway alterations. Proteomic analysis identified 76 upregulated and 33 downregulated genes, with key biomarkers [ SERPINA1 (0.92), PZP (0.90), FGA (0.91), TLN1 (0.94), FGB (0.95)] displaying AUC-ROC ≥ 0.90. Pan-omics fusion followed by STRING analysis identified 20 central hub genes strongly correlated with congenital tooth agenesis signaling. Conclusion: This study pioneers the systemic association of CTA with ecto-mesodermal diseases, revealing novel signatures, disrupted pathways, and therapeutic targets. Graphical

25 April 2023 in medRxiv
Verified
Preprint
Open access
PDF file
CDChandra Devi
Chandra Devi
SSShivendra Singh
Shivendra Singh
BMBhagyalaxmi Mohapatra
Bhagyalaxmi Mohapatra
AKAshok Kumar
Ashok Kumar
SVSanjay Vikrant
Sanjay Vikrant
PDParimal Das
Parimal Das
Autosomal Dominant Polycystic Kidney Disease is characterized by renal cyst development, often leading to kidney enlargement and failure. We conducted whole exome sequencing on 14 participants (12 families) from an Indian cohort. Our analysis revealed a spectrum of genetic variants, predominantly in the PKD1. These in PKD1 included missense variants such as p.Glu2937Lys (c.8809G>A) and p.Gly2310Arg (c.6928G>A), p.Asp2095Gly (c.6284A>G), p.Thr938Met (c.2813C>T), p.Trp967Arg (c.2899T>C), p.Glu593* (c.1777G>T), frameshift variants p.Gln149fs*141 (c.445delC), p.Ser3305fs*84 (c.9914_9915delCT), p.His1347fs*83 (c.4041_4042delCA), and p.Leu2776fs*87(c.8327_8363delTGGCGGGCGAGGAGATCGTGGCCCAGGGCAAGCGCTC), intronic splice site variant c.8017-3C>G, nonsense variant p.Glu593* (c.1777G>T) and in PKD2 missense variant p.Ser370Asn (c.1109G>A). While one individual carried intronic (c.2358+5G>A) and 3’UTR (c.*174G>T) variants in PKD2 only another individual carried variants in both PKD1 and PKD2 , suggesting potential genetic complexity. Clinical data revealed diverse presentations. Age at diagnosis varied widely. Patients with frameshift variants exhibited earlier onset and severe manifestations, including bilateral ADPKD. One proband had right unilateral ADPKD. Involvement of liver, a common extra-renal manifestation, was also observed. Heterogeneity at phenotypic and at allelic level was observed in our cohort. In this study, using WES of a trio, a frameshift-truncation deletion [c.32del/p.Leu11ArgfsTer61] in MIOX was found to be associated with the disease shared by both the affected and early diagnosed mother and daughter carrying PKD1 missense variant, which had not been previously reported in ADPKD. Further, differential gene expression analysis using data from GEO database showed reduced MIOX expression in ADPKD cystic samples compared to minimal cystic tissues and controls. MIOX is an enzyme specific to renal tubules and catalyses the initial step of the kidney-based myoinositol catabolism. Both affected candidates also shared benign variants and other variations of uncertain significance which may influence the disease development. Further functional analysis will clarify how MIOX contributes to the disease. The study limitations include the small sample size and the need for validation in larger cohorts. Our findings highlight the importance of genetic analysis in ADPKD management especially to facilitate personalized therapeutic strategies. Highlights: Identified variants in PKD1 and PKD2 through whole exome sequencing in ADPKD patients, affecting different protein regions. Variants include non-synonymous coding changes, frame-shift deletions, and splice site alterations. Clinical features and age at diagnosis varied widely, with common symptoms including flank pain, fatigue. Frameshift deletion in MIOX , associated in one PKD1 trio, implicates its role in ADPKD pathogenesis. DGE analysis of dataset from database reveals downregulation of MIOX in ADPKD tissue samples highlighting its role in potential molecular pathways in ADPKD progression. Graphical